미약사가 전하는 1분 Healthcare Stocks 뉴스, Great News For Biogen & Humanity

Ahoy, dear reader! If Aristotle and Steve Jobs sat down for a cuppa, they might've chatted about the metaphysics of an iPhone. But today, as Plato cracks a joke to Elon Musk, we're diving deep into the world's financial theater, where molecules and dollars waltz. 🕺💃

The Starlet: 바이오진 (Biojin)

Let's talk about today's big headline. Or should I say, the song of the day that has the market humming its tune? It's none other than 바이오진 (Biojin)!

But before you ask, “What's the buzz?”, let me spill the beans: 바이오진 has not one, but two intriguing updates. First off, the fda has given a thumbs up to an aos drug – imagine Aristotle giving a nod to a new philosophy, that’s the level of approval we're talking about. Now, if that isn’t exciting enough, the cms has made a proclamation – if the fd grants permission, they will, too, green-light the same drug at a whopping annual rate of 26,500 dollars! 🚀

The statement from cms might remind one of Galileo daringly asserting the Earth revolves around the Sun. It's audacious, groundbreaking, and could change the way we look at things.

The Understudies: Other Stocks

While 바이오진 might be stealing the limelight, there are other players on the stage. No fireworks, no jaw-dropping revelations, but significant nonetheless. 휴메나 인슈런스 (Humana Insurance) is jumping higher than ever, perhaps doing its own version of the moonwalk. Following closely are 덱스컴 and 바이어진, both riding the wave and giving 바이오진 a run for its money.

Aftermarket Whispers and Melodies

As the curtain falls on the day, the after-market doesn't rest. Just as Maria Popova might dig into the archives for a forgotten gem, an upgrade emerges from a group for 이민택스 (LeeMinTax) - a company you might want to keep an eye on. They’ve been consistent all year round, just like Leonardo da Vinci sketching masterpieces one after the other.

The Verdict? Times are exciting, my friend. As Nelson Mandela might say, "It always seems impossible until it's done." So, keep your ears to the ground, because the financial symphony is playing a captivating tune. And you wouldn't want to miss the next movement, would you? 😉

Now, go forth, dear reader, with the buzzing excitement of the market in one hand and the wisdom of the ages in the other. Dance to the rhythm of the stocks, but always with a twinkle in your eye and a chuckle at the ready! 🎉